257 related articles for article (PubMed ID: 29978912)
21. Liquid chromatography-tandem mass spectrometry for the quantification of moxifloxacin, ciprofloxacin, daptomycin, caspofungin, and isavuconazole in human plasma.
Hösl J; Gessner A; El-Najjar N
J Pharm Biomed Anal; 2018 Aug; 157():92-99. PubMed ID: 29777985
[TBL] [Abstract][Full Text] [Related]
22. Quantification of Serum Voriconazole, Isavuconazole, and Posaconazole by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
Smith A; Dowis J; French D
Curr Protoc Toxicol; 2018 May; 76(1):e47. PubMed ID: 30040225
[TBL] [Abstract][Full Text] [Related]
23. Determination of rifampicin in human plasma by high-performance liquid chromatography coupled with ultraviolet detection after automatized solid-liquid extraction.
Louveau B; Fernandez C; Zahr N; Sauvageon-Martre H; Maslanka P; Faure P; Mourah S; Goldwirt L
Biomed Chromatogr; 2016 Dec; 30(12):2009-2015. PubMed ID: 27280327
[TBL] [Abstract][Full Text] [Related]
24. Development and Validation of an HPLC Method for Quantification of Filgotinib, a Novel JAK-1 Inhibitor in Mice Plasma: Application to a Pharmacokinetic Study.
Zakkula A; Pulipati S; Dittakavi S; Bestha RM; Zainuddin M; Trivedi RK; Mullangi R
Drug Res (Stuttg); 2020 May; 70(5):233-238. PubMed ID: 32289835
[TBL] [Abstract][Full Text] [Related]
25. An efficient HPLC method for the quantitative determination of atazanavir in human plasma suitable for bioequivalence and pharmacokinetic studies in healthy human subjects.
Müller AC; Kanfer I
J Pharm Biomed Anal; 2010 Sep; 53(1):113-8. PubMed ID: 20395105
[TBL] [Abstract][Full Text] [Related]
26. Two Phase 1, Open-Label, Mass Balance Studies to Determine the Pharmacokinetics of
Townsend R; Kato K; Hale C; Kowalski D; Lademacher C; Yamazaki T; Akhtar S; Desai A
Clin Pharmacol Drug Dev; 2018 Feb; 7(2):207-216. PubMed ID: 28750160
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Isavuconazole serum concentrations after enteral feeding tube administration in a hospitalized cohort: A case series.
Spivey J; Wrenn R; Liu B; Maziarz E; Kram B
J Clin Pharm Ther; 2021 Apr; 46(2):528-531. PubMed ID: 33247433
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of cligosiban in dog plasma after oral administration by liquid chromatography electrospray ionization tandem mass spectrometry.
Xi W; Zou Q; Ouyang P
Biomed Chromatogr; 2019 Oct; 33(10):e4611. PubMed ID: 31145820
[TBL] [Abstract][Full Text] [Related]
29. Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
Miceli MH; Kauffman CA
Clin Infect Dis; 2015 Nov; 61(10):1558-65. PubMed ID: 26179012
[TBL] [Abstract][Full Text] [Related]
30. Quantification of tipranavir in human plasma by high-performance liquid chromatography with UV detection.
Giraud E; Rey E; Tréluyer JM; Pons G; Jullien V
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):86-90. PubMed ID: 16260190
[TBL] [Abstract][Full Text] [Related]
31. A simple and rapid HPLC-UV method for the determination of retigabine in human plasma.
Franco V; Baruffi K; Gatti G; Marchiselli R; Fattore C; Canevini MP; Crema F; Perucca E
Biomed Chromatogr; 2018 May; 32(5):e4168. PubMed ID: 29235121
[TBL] [Abstract][Full Text] [Related]
32. High-performance liquid chromatographic analysis of the anti-fungal agent SCH 56592 in dog serum.
Kim H; Likhari P; Kumari P; Lin CC; Nomeir AA
J Chromatogr B Biomed Sci Appl; 2000 Jan; 738(1):93-8. PubMed ID: 10778930
[TBL] [Abstract][Full Text] [Related]
33. Quantitative determination of regorafenib and its two major metabolites in human plasma with high-performance liquid chromatography and ultraviolet detection.
Fujita K; Miura M; Shibata H
Biomed Chromatogr; 2016 Oct; 30(10):1611-7. PubMed ID: 27037679
[TBL] [Abstract][Full Text] [Related]
34. Isavuconazole: Pharmacology, Pharmacodynamics, and Current Clinical Experience with a New Triazole Antifungal Agent.
Rybak JM; Marx KR; Nishimoto AT; Rogers PD
Pharmacotherapy; 2015 Nov; 35(11):1037-51. PubMed ID: 26598096
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of an HPLC-UV method for pazopanib quantification in human plasma and application to patients with cancer in routine clinical practice.
Escudero-Ortiz V; Pérez-Ruixo JJ; Valenzuela B
Ther Drug Monit; 2015 Apr; 37(2):172-9. PubMed ID: 25072946
[TBL] [Abstract][Full Text] [Related]
36. Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.
Seyedmousavi S; Verweij PE; Mouton JW
Expert Rev Anti Infect Ther; 2015 Jan; 13(1):9-27. PubMed ID: 25488140
[TBL] [Abstract][Full Text] [Related]
37. Validated HPLC method for simultaneous quantification of mutant IDH1/2 inhibitors (enasidenib, ivosidenib and vorasidenib) in mouse plasma: Application to a pharmacokinetic study.
Zakkula A; Dittakavi S; Maniyar MM; Syed N; Sulochana SP; Zainuddin M; Mullangi R
Biomed Chromatogr; 2019 Nov; 33(11):e4658. PubMed ID: 31325170
[TBL] [Abstract][Full Text] [Related]
38. Variability of voriconazole plasma levels measured by new high-performance liquid chromatography and bioassay methods.
Pascual A; Nieth V; Calandra T; Bille J; Bolay S; Decosterd LA; Buclin T; Majcherczyk PA; Sanglard D; Marchetti O
Antimicrob Agents Chemother; 2007 Jan; 51(1):137-43. PubMed ID: 17088483
[TBL] [Abstract][Full Text] [Related]
39. Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
Ledoux MP; Denis J; Nivoix Y; Herbrecht R
J Mycol Med; 2018 Mar; 28(1):15-22. PubMed ID: 29551442
[TBL] [Abstract][Full Text] [Related]
40. Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic study.
Venkatesh G; Majid MI; Ramanathan S; Mansor SM; Nair NK; Croft SL; Navaratnam V
Biomed Chromatogr; 2008 May; 22(5):535-41. PubMed ID: 18205140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
